Key facts
- This page summarizes Jaime Sepulveda's Form 4 filing for HilleVax, Inc. (HLVX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 30 Apr 2025, 07:00.
Jaime Sepulveda - 06 Jun 2024 Form 4 Insider Report for HilleVax, Inc. (HLVX)
- Reporting relationship
- Director
- Issuer ticker
- HLVX
- Reported as of
- 06 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Apr 2025, 07:00:09 UTC
- Prior SEC filing
- 09 Jun 2023
- Next SEC filing
- 25 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Bavier, Attorney-in-Fact for Jaime Sepulveda
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jaime Sepulveda filed Form 4 for HilleVax, Inc. (HLVX) on 30 Apr 2025.
Change
- Previous filing in this sequence was filed on 09 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HLVX
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +22,500
- Change %
- Price
- $0.000000
- Shares after
- 22,500
- Date
- 06 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,500
- Exercise price
- $13.75
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option was granted pursuant to the Registrant's non-employee director compensation program. The option shall vest and/or become exercisable on the first to occur of (i) the first anniversary of the grant date or (ii) the next occurring annual meeting of our stockholders, in each case, subject to the non-employee director continuing in service on our board of directors through such vesting dates.